European Medicines Verification Organisation

What European Medicines Verification Organisation does

European Medicines Verification Organisation (EMVO) is a Belgian non-profit association (EMVO asbl), founded in 2015 and headquartered in Brussels, that operates the European Medicines Verification System (EMVS), a pan-European IT platform mandated by EU Directive 2011/62/EU (the Falsified Medicines Directive). EMVO's core function is to operate the central European Hub, which connects national medicine verification systems across 29 participating countries, providing secure data flow for end-to-end verification of prescription medicines to prevent falsified products from entering the legal supply chain. The platform serves 2,900+ marketing authorisation holders, 4,000+ wholesale distribution authorisation holders, 115,000+ commercial pharmacies, and 6,000+ hospital pharmacies.

The product surface spans five components: the European Hub (central infrastructure), the OBP Portal (onboarding and product data management for marketing authorisation holders, currently at v5.0.0), the EVI Subscription (a recurring intelligence and analytics service), a Scanner Tool (point-of-dispensing verification), and the European Alert Management System (coordination of suspected-falsification alerts). Recent releases include EU Hub Release 1.20 with mandatory schema upgrades and OBP Portal 5.0.0 with enhanced data visibility and issue tracking.

EMVO is funded through membership and subscription fees from its founding stakeholders (EFPIA, Medicines for Europe, PGEU, GIRP, Affordable Medicines Europe) and affiliate stakeholders (EAHP, HOPE), with a stakeholder-led governance model collectively representing pharmaceutical manufacturers, generic and biosimilar producers, community pharmacists, wholesalers, parallel distributors, hospital pharmacists, and hospital federations. GTM is stakeholder-led and event-driven, anchored by the annual EMVS Forum, professional website and helpdesk channels, and ongoing schema/platform rollouts. Headcount is small (11–50), consistent with a lean operator relying on its multi-stakeholder governance rather than commercial scale.

Name

European Medicines Verification Organisation

Legal name

EMVO asbl

Website

https://emvo-medicines.eu

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

European Medicines Verification Organisation (EMVO) is a Belgian non-profit that operates the European Medicines Verification System, a mandated EU-wide IT platform connecting 29 countries' national systems to detect falsified medicines across the pharmaceutical supply chain.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Verification

NAICS

Medical and Diagnostic Laboratories (62151), Computer Facilities Management Services (541513)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Testing Laboratories (8734)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industries

Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance (HLACAKAJ), Medical Device Regulators (HLAJADAC)

Keywords

• Pharmaceutical verification
• Medicines authentication
• Supply chain security
• Falsified medicines prevention
• Regulatory compliance platform

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Infrastructure, Others

Revenue model

1. Membership/Subscription fees: EMVO operates as a Belgian non-profit organisation representing stakeholders united in securing the legal supply chain. Revenue appears to come from membership fees from founding and affiliate stakeholders including EFPIA, Medicines for Europe, PGEU, GIRP, and Affordable Medicines Europe.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

EMVO operates the European Medicines Verification System (EMVS), a pan-European IT platform that connects the national medicine verification systems of 29 countries to a central European Hub, enabling end-to-end verification of medicines and secure data management to prevent falsified medicines from entering the legal supply chain. The system is mandated by the EU Falsified Medicines Directive (2011/62/EU) and serves pharmaceutical companies, wholesale distributors, and pharmacies across Europe.

Product overview

EMVO operates the European Medicines Verification System (EMVS), a pan-European IT platform for ensuring medicine authenticity through end-to-end verification and secure data management. The system connects 29 national medicine verification systems to a central European Hub. The portfolio includes the OBP Portal for pharmaceutical company onboarding and data management, the EVI Subscription service for verification intelligence, a Scanner Tool for dispensing point verification, and the European Alert Management System. EMVS connects over 2,900 Marketing Authorisation Holders, 4,000+ Wholesale Distribution Authorisation Holders, 115,000+ Commercial pharmacies, and 6,000+ Hospital pharmacies across Europe.

Differentiator

Problem solved

Functional benefit

Products and services

• European Medicines Verification System (EMVS) A pan-European IT system that ensures medicine authenticity through end-to-end verification and secure data management, connecting the national medicine verification systems of 29 countries to the central European Hub. It serves pharmaceutical companies, wholesale distributors, and pharmacies across Europe.
• OBP Portal Online portal for Marketing Authorisation Holders (MAHs) and other On-boarding Partners to register, upload product master data, manage their connection to the EMVS, and monitor system transactions. Version 5.0.0 offers improved data visibility and validation, enhanced issue tracking, and better usability.
• EVI Subscription

Quantifiable outcome

• 29 countries connected to the European Medicines Verification System
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and secondary.

• EFPIA (European Federation of Pharmaceutical Industries and Associations)coreStrategic or Co-development PartnerEFPIA is a founding stakeholder of EMVO, representing the research-based pharmaceutical industry in Europe. As a founding stakeholder, EFPIA plays a governance role in EMVO's strategic direction and operations.
• Medicines for Europe (European Generic and Biosimilar Medicines Association)coreStrategic or Co-development PartnerMedicines for Europe is a founding stakeholder of EMVO, representing generic and biosimilar medicines manufacturers. Contributes to governance and strategic direction as a founding member.
• PGEU (Pharmaceutical Group of the European Union)coreStrategic or Co-development PartnerPGEU is a founding stakeholder representing community pharmacists at EU level. Plays a governance role in EMVO as a founding member organisation.
• GIRP (European Healthcare Distribution Association)coreStrategic or Co-development PartnerGIRP is a founding stakeholder representing pharmaceutical wholesale distribution in Europe. Contributes to EMVO governance as a founding member.
• Affordable Medicines EuropecoreStrategic or Co-development PartnerAffordable Medicines Europe is a founding stakeholder representing parallel distribution companies. Serves as a founding member with governance responsibilities.
• EAHP (European Association of Hospital Pharmacists)secondaryStrategic or Co-development PartnerEAHP is an affiliate stakeholder of EMVO, representing hospital pharmacists across Europe. Provides input on hospital pharmacy perspectives and practices.
• HOPE (European Hospital and Healthcare Federation)secondaryStrategic or Co-development PartnerHOPE is an affiliate stakeholder of EMVO, representing hospitals and healthcare at EU level. Contributes healthcare system perspectives to EMVO activities.

Scale indicators7 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• European Medicines Agency (EMA): EMA is the EU's regulatory agency overseeing medicines authorisation and pharmacovigilance. Comparable as a peer within the same healthcare regulatory governance ecosystem in which EMVO operates, though with a broader regulatory remit rather than the serialisation focus.
• SAP (Advanced Track and Trace for Pharmaceuticals / ATTP): SAP's ATTP is a major commercial pharmaceutical serialisation platform used by manufacturers to comply with track-and-trace mandates globally. Comparable as a commercial supplier working within or alongside regulatory verification regimes analogous to EMVS.

Others

• RxBenefits / MarkVision (Pharma Supply Chain IT): Adjacent pharma supply-chain IT and data analytics providers serving manufacturers and pharmacies with compliance and dispensing solutions. Comparable as ecosystem participants building tooling that interacts with EMVS endpoints at the dispensing or supply-chain node.

Direct peers

• securPharm (Germany NMVO): securPharm operates the German national medicines verification system (national blueprint of the FMD), directly connected to and governed with EMVO via the European Hub. It is the clearest direct functional peer, sharing the same regulatory regime and verification model at the national level.
• NMVO Italia: Italy's NMVO operates the national verification system connected to EMVO and is referenced by EMVO in onboarding communications. Functionally and structurally a direct national-level peer.
• Medicine Verification (France): France-MVO runs the French national medicines verification system under the same EU FMD framework, interoperating with EMVO's European Hub. Directly comparable as a national-level operator within EMVO's stakeholder network.

Emerging players

• TraceLink: TraceLink is a leading commercial pharmaceutical serialisation and track-and-trace platform serving DSCSA (US) and other markets. Comparable as a competing/implementation-level provider in pharmaceutical supply-chain verification, although built on a commercial SaaS model rather than an EU-mandated non-profit model.
• Movilitas Consulting: Movilitas provides regulatory compliance and serialisation consulting/technology for the pharmaceutical supply chain (FMD, DSCSA). Comparable as an adjacent implementation and compliance services peer operating in the same regulatory ecosystem.
• OPTEL Group: OPTEL offers traceability, serialisation, and supply-chain transparency solutions for pharmaceuticals, including FMD compliance tooling. Comparable as an emerging player providing competing/parallel verification capability at the supplier level.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/emvo_official
• LinkedInlinkedin.com/company/emvo

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Medicines Verification Organisation